Bone Biologics shares rise 13.37% intraday after extending rhNELL-1 shelf life to 24 months, enhancing manufacturing efficiency and supply chain flexibility for its bone regeneration products.
ByAinvest
Tuesday, Dec 23, 2025 9:57 am ET1min read
BBLG--
Bone Biologics surged 13.37% intraday, as the company announced an extension of the shelf life of its rhNELL-1 product to 24 months, enhancing manufacturing efficiency, inventory management, and supply chain flexibility to support its long-term commercial strategy. The company specializes in developing bone regeneration medical devices for spinal fusion, with rhNELL-1 combined with DBM offering targeted bone regeneration control and potential as an FDA-classified combination device/drug product.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet